Lino Maria Maddalena, Atanasoski Suzana, Kvajo Mirna, Fayard Bérengère, Moreno Eliza, Brenner Hans Rudolf, Suter Ueli, Monard Denis
Friedrich Miescher Institute for Biomedical Research, CH-4058 Basel, Switzerland.
J Neurosci. 2007 Apr 4;27(14):3677-85. doi: 10.1523/JNEUROSCI.0277-07.2007.
Multiple molecular mechanisms influence nerve regeneration. Because serine proteases were shown to affect peripheral nerve regeneration, we performed nerve crush experiments to study synapse reinnervation in adult mice lacking the serpin protease nexin-1 (PN-1). PN-1 is a potent endogenous inhibitor of thrombin, trypsin, tissue plasminogen activators (tPAs), and urokinase plasminogen activators. Compared with the wild type, a significant delay in synapse reinnervation was detected in PN-1 knock-out (KO) animals, which was associated with both reduced proliferation and increased apoptosis of Schwann cells. Various factors known to affect Schwann cells were also altered. Fibrin deposits, tPA activity, mature BDNF, and the low-affinity p75 neurotrophin receptor were increased in injured sciatic nerves of mutant mice. To test whether the absence of PN-1 in Schwann cells or in the axon caused delay in reinnervation, PN-1 was overexpressed exclusively in the nerves of PN-1 KO mice. Neuronal PN-1 expression did not rescue the delayed reinnervation. The results suggest that Schwann cell-derived PN-1 is crucial for proper reinnervation through its contribution to the autocrine control of proliferation and survival. Thus, the precise balance between distinct proteases and serpins such as PN-1 can modulate the overall impact on the kinetics of recovery.
多种分子机制影响神经再生。由于丝氨酸蛋白酶已被证明会影响周围神经再生,我们进行了神经挤压实验,以研究缺乏丝氨酸蛋白酶抑制剂神经纤溶酶原激活剂-1(PN-1)的成年小鼠的突触再支配情况。PN-1是凝血酶、胰蛋白酶、组织纤溶酶原激活剂(tPA)和尿激酶型纤溶酶原激活剂的一种有效的内源性抑制剂。与野生型相比,在PN-1基因敲除(KO)动物中检测到突触再支配明显延迟,这与雪旺细胞增殖减少和凋亡增加有关。已知影响雪旺细胞的各种因素也发生了改变。在突变小鼠受伤的坐骨神经中,纤维蛋白沉积、tPA活性、成熟的脑源性神经营养因子(BDNF)和低亲和力p75神经营养因子受体增加。为了测试雪旺细胞或轴突中PN-缺乏是否导致再支配延迟,仅在PN-1 KO小鼠的神经中过表达PN-1。神经元PN-1的表达并不能挽救延迟的再支配。结果表明,雪旺细胞衍生的PN-1通过对增殖和存活的自分泌控制,对正确的再支配至关重要。因此,不同蛋白酶和丝氨酸蛋白酶抑制剂(如PN-1)之间的精确平衡可以调节对恢复动力学的总体影响。